这是一篇来自已证抗体库的有关人类 Nbs1的综述,是根据42篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Nbs1 抗体。
Nbs1 同义词: AT-V1; AT-V2; ATV; NBS; NBS1; P95; nibrin; Nijmegen breakage syndrome 1 (nibrin); cell cycle regulatory protein p95; p95 protein of the MRE11/RAD50 complex

Novus Biologicals
兔 多克隆
  • 免疫印迹; 人类; 图 s2b
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143SS)被用于被用于免疫印迹在人类样本上 (图 s2b). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 图 7a
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫细胞化学在人类样本上 (图 7a). J Virol (2017) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:300; 图 2
Novus Biologicals Nbs1抗体(Novus Biological, NB100-143)被用于被用于免疫细胞化学在人类样本上浓度为1:300 (图 2). J Cell Sci (2016) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:1000; 图 3
Novus Biologicals Nbs1抗体(Novus, NB100-143)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 3). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:200; 图 3
  • 免疫印迹; 人类; 1:8000; 图 3
Novus Biologicals Nbs1抗体(Novus biological, NB100-143)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 3) 和 被用于免疫印迹在人类样本上浓度为1:8000 (图 3). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹基因敲除验证; 小鼠; 图 1
Novus Biologicals Nbs1抗体(Novus, NB100-143)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 1). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(1D7)
  • 免疫印迹; 小鼠; 图 2a
Novus Biologicals Nbs1抗体(Novus Biologicals, catalog NB100-221)被用于被用于免疫印迹在小鼠样本上 (图 2a). J Clin Invest (2015) ncbi
兔 多克隆
  • 染色质免疫沉淀 ; 人类; 图 1
  • 免疫沉淀; 人类
  • 免疫印迹; 人类
Novus Biologicals Nbs1抗体(Novus, NB100-143)被用于被用于染色质免疫沉淀 在人类样本上 (图 1), 被用于免疫沉淀在人类样本上 和 被用于免疫印迹在人类样本上. Cancer Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫印迹在人类样本上. J Virol (2015) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:100
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫细胞化学在人类样本上浓度为1:100. Proc Natl Acad Sci U S A (2014) ncbi
兔 多克隆
  • 免疫沉淀; 人类; 图 6
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫沉淀在人类样本上 (图 6). Nat Cell Biol (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠; 图 s3
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫细胞化学在小鼠样本上 (图 s3). FASEB J (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠
  • 免疫印迹; 小鼠
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫细胞化学在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Cell Rep (2012) ncbi
兔 多克隆
  • 免疫印迹; 人类
Novus Biologicals Nbs1抗体(Novus, NB100-143)被用于被用于免疫印迹在人类样本上. Mitochondrion (2013) ncbi
兔 多克隆
  • 免疫细胞化学; 猕猴; 图 6
Novus Biologicals Nbs1抗体(Novus Biologicals, NB100-143)被用于被用于免疫细胞化学在猕猴样本上 (图 6). J Virol (2010) ncbi
艾博抗(上海)贸易有限公司
兔 单克隆(Y112)
  • 免疫印迹; 人类; 图 2a, 5b
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab32074)被用于被用于免疫印迹在人类样本上 (图 2a, 5b). Genes Dev (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2a
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab47272)被用于被用于免疫印迹在人类样本上 (图 2a). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab23996)被用于被用于免疫印迹在人类样本上 (图 2). PLoS Genet (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab47272)被用于被用于免疫印迹在人类样本上 (图 2). PLoS Genet (2016) ncbi
兔 单克隆(Y112)
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab32074)被用于被用于免疫印迹在人类样本上 (图 1). BMC Cancer (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab47272)被用于被用于免疫印迹在人类样本上 (图 1). Viruses (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab23996)被用于被用于免疫印迹在人类样本上 (图 1). Viruses (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab47272)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
GeneTex
小鼠 单克隆(1D7)
  • 免疫印迹; 人类; 1:1000; 图 3a
GeneTex Nbs1抗体(Genetex, GTX70224)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Mol Oncol (2016) ncbi
兔 多克隆
  • 免疫组化; 人类; 图 6
  • 免疫印迹; 人类; 图 6
GeneTex Nbs1抗体(Genetex, GTX30125)被用于被用于免疫组化在人类样本上 (图 6) 和 被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(1C3)
  • 免疫印迹; 人类; 图 s1c
GeneTex Nbs1抗体(Gene Tex, GTX70222)被用于被用于免疫印迹在人类样本上 (图 s1c). Cell Death Differ (2016) ncbi
小鼠 单克隆(1C3)
  • 免疫印迹; 人类; 图 5
GeneTex Nbs1抗体(GeneTex, GTX70222)被用于被用于免疫印迹在人类样本上 (图 5). BMC Biol (2015) ncbi
小鼠 单克隆(1D7)
  • 免疫沉淀; 人类; 图 6
GeneTex Nbs1抗体(Genetex, GTX70224)被用于被用于免疫沉淀在人类样本上 (图 6). Nat Cell Biol (2014) ncbi
小鼠 单克隆(1D7)
  • 免疫印迹; 人类
GeneTex Nbs1抗体(Genetex, GTX70224)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(1D7)
  • 免疫印迹; 人类; 图 1
GeneTex Nbs1抗体(GeneTex, GTX70224)被用于被用于免疫印迹在人类样本上 (图 1). Oncogenesis (2012) ncbi
小鼠 单克隆(1C3)
  • 免疫印迹; 人类
GeneTex Nbs1抗体(GeneTex, #GTX70222)被用于被用于免疫印迹在人类样本上. Cancer Res (2011) ncbi
西格玛奥德里奇
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 图 s1
西格玛奥德里奇 Nbs1抗体(Sigma, HPA001429)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 s1). Oncotarget (2016) ncbi
赛信通(上海)生物试剂有限公司
兔 多克隆
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling, 3002)被用于被用于免疫印迹在人类样本上 (图 4c). Oncogene (2019) ncbi
兔 多克隆
  • reverse phase protein lysate microarray; 小鼠; 图 s1.b,c
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling Technology, 3002)被用于被用于reverse phase protein lysate microarray在小鼠样本上 (图 s1.b,c). EMBO Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图 4
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling Technology, 3001)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4). Nat Genet (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling, cat# 3002)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. EMBO J (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 7a
赛信通(上海)生物试剂有限公司 Nbs1抗体(CST, 3002)被用于被用于免疫印迹在人类样本上 (图 7a). Oncogene (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2b
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling, 3002)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2b). Nat Neurosci (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling, 3001)被用于被用于免疫印迹在人类样本上. Biochem Biophys Res Commun (2014) ncbi
碧迪BD
小鼠 单克隆(13/P95PKL)
  • 免疫印迹; 人类; 图 1
碧迪BD Nbs1抗体(BD Transduction Laboratorie, 611388)被用于被用于免疫印迹在人类样本上 (图 1). PLoS Pathog (2015) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫细胞化学; 小鼠; 1:10; 图 3g,h
碧迪BD Nbs1抗体(BD Biosciences, 611870)被用于被用于免疫细胞化学在小鼠样本上浓度为1:10 (图 3g,h). Development (2015) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫印迹; 人类
碧迪BD Nbs1抗体(BD Biosciences, 611871)被用于被用于免疫印迹在人类样本上. Carcinogenesis (2014) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫细胞化学; 小鼠
碧迪BD Nbs1抗体(BD Biosciences, 611871)被用于被用于免疫细胞化学在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫印迹; 人类
碧迪BD Nbs1抗体(BD, 611870)被用于被用于免疫印迹在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫印迹; 小鼠
碧迪BD Nbs1抗体(BD Biosciences, 611871)被用于被用于免疫印迹在小鼠样本上. Int J Cancer (2013) ncbi
默克密理博中国
兔 单克隆(Y112)
  • 免疫组化-冰冻切片; 小鼠; 图 s1
默克密理博中国 Nbs1抗体(Millipore, 04-236)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 s1). Oncotarget (2016) ncbi
兔 单克隆(Y112)
  • 免疫印迹; 小鼠; 图 6
默克密理博中国 Nbs1抗体(Merck Millipore, 04-236)被用于被用于免疫印迹在小鼠样本上 (图 6). Oncogene (2016) ncbi
小鼠 单克隆(2G2E3)
  • 免疫印迹; 人类
默克密理博中国 Nbs1抗体(Upstate, 05-663)被用于被用于免疫印迹在人类样本上. Carcinogenesis (2014) ncbi
文章列表
  1. Urtishak K, Wang L, Culjkovic Kraljacic B, Davenport J, Porazzi P, Vincent T, et al. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. Oncogene. 2019;38:2241-2262 pubmed 出版商
  2. Smith E, Gole B, Willis N, Soria R, Starnes L, Krumpelbeck E, et al. DEK is required for homologous recombination repair of DNA breaks. Sci Rep. 2017;7:44662 pubmed 出版商
  3. Gong Y, Handa N, Kowalczykowski S, de Lange T. PHF11 promotes DSB resection, ATR signaling, and HR. Genes Dev. 2017;31:46-58 pubmed 出版商
  4. Campos León K, Wijendra K, Siddiqa A, Pentland I, Feeney K, Knapman A, et al. Association of Human Papillomavirus 16 E2 with Rad50-Interacting Protein 1 Enhances Viral DNA Replication. J Virol. 2017;91: pubmed 出版商
  5. Weber A, Drobnitzky N, Devery A, Bokobza S, Adams R, Maughan T, et al. Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer. Oncotarget. 2016;7:60807-60822 pubmed 出版商
  6. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed 出版商
  7. Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Mol Med. 2016;8:527-49 pubmed 出版商
  8. Byrd P, Stewart G, Smith A, Eaton C, Taylor A, Guy C, et al. A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development. PLoS Genet. 2016;12:e1005945 pubmed 出版商
  9. Chang L, Huang J, Wang K, Li J, Yan R, Zhu L, et al. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy. BMC Cancer. 2016;16:190 pubmed 出版商
  10. Francia S, Cabrini M, Matti V, Oldani A, d Adda di Fagagna F. DICER, DROSHA and DNA damage response RNAs are necessary for the secondary recruitment of DNA damage response factors. J Cell Sci. 2016;129:1468-76 pubmed 出版商
  11. Rasmussen R, Gajjar M, Jensen K, Hamerlik P. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma. Mol Oncol. 2016;10:751-63 pubmed 出版商
  12. Ge C, Che L, Du C. The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex. PLoS ONE. 2015;10:e0144957 pubmed 出版商
  13. Harley M, Murina O, Leitch A, Higgs M, Bicknell L, Yigit G, et al. TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism. Nat Genet. 2016;48:36-43 pubmed 出版商
  14. Xing M, Wang X, Palmai Pallag T, Shen H, Helleday T, Hickson I, et al. Acute MUS81 depletion leads to replication fork slowing and a constitutive DNA damage response. Oncotarget. 2015;6:37638-46 pubmed 出版商
  15. Gramolelli S, Weidner Glunde M, Abere B, Viejo Borbolla A, Bala K, Rückert J, et al. Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells. PLoS Pathog. 2015;11:e1005105 pubmed 出版商
  16. Shimada M, Dumitrache L, Russell H, McKinnon P. Polynucleotide kinase-phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability. EMBO J. 2015;34:2465-80 pubmed 出版商
  17. Lee K, Im J, Shibata E, Park J, Handa N, Kowalczykowski S, et al. MCM8-9 complex promotes resection of double-strand break ends by MRE11-RAD50-NBS1 complex. Nat Commun. 2015;6:7744 pubmed 出版商
  18. Fedoriw A, Menon D, Kim Y, Mu W, Magnuson T. Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes. Development. 2015;142:2972-80 pubmed 出版商
  19. Rein K, Yanez D, Terré B, Palenzuela L, Aivio S, Wei K, et al. EXO1 is critical for embryogenesis and the DNA damage response in mice with a hypomorphic Nbs1 allele. Nucleic Acids Res. 2015;43:7371-87 pubmed 出版商
  20. Wang J, Chen S, Sun C, Chien T, Chern Y. A central role of TRAX in the ATM-mediated DNA repair. Oncogene. 2016;35:1657-70 pubmed 出版商
  21. Xie L, Pi X, Townley Tilson W, Li N, Wehrens X, Entman M, et al. PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban. J Clin Invest. 2015;125:2759-71 pubmed 出版商
  22. Petroni M, Sardina F, Heil C, Sahún Roncero M, Colicchia V, Veschi V, et al. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ. 2016;23:197-206 pubmed 出版商
  23. Hollingworth R, Skalka G, Stewart G, Hislop A, Blackbourn D, Grand R. Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. Viruses. 2015;7:2908-27 pubmed 出版商
  24. Goldstein M, Kastan M. Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding. Cancer Res. 2015;75:2699-707 pubmed 出版商
  25. Harten S, Oey H, Bourke L, Bharti V, Isbel L, Daxinger L, et al. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers. BMC Biol. 2015;13:21 pubmed 出版商
  26. Nakahara T, Tanaka K, Ohno S, Egawa N, Yugawa T, Kiyono T. Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1. J Virol. 2015;89:5040-59 pubmed 出版商
  27. Ciccia A, Huang J, Izhar L, Sowa M, Harper J, Elledge S. Treacher Collins syndrome TCOF1 protein cooperates with NBS1 in the DNA damage response. Proc Natl Acad Sci U S A. 2014;111:18631-6 pubmed 出版商
  28. Wei F, Ojo D, Lin X, Wong N, He L, Yan J, et al. BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation. Oncogene. 2015;34:3063-75 pubmed 出版商
  29. Larsen D, Hari F, Clapperton J, Gwerder M, Gutsche K, Altmeyer M, et al. The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nat Cell Biol. 2014;16:792-803 pubmed 出版商
  30. Shamanna R, Singh D, Lu H, Mirey G, Keijzers G, Salles B, et al. RECQ helicase RECQL4 participates in non-homologous end joining and interacts with the Ku complex. Carcinogenesis. 2014;35:2415-24 pubmed 出版商
  31. Lee J, Guo Z, Myler L, Zheng S, Paull T. Direct activation of ATM by resveratrol under oxidizing conditions. PLoS ONE. 2014;9:e97969 pubmed 出版商
  32. Katyal S, Lee Y, Nitiss K, Downing S, Li Y, Shimada M, et al. Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes. Nat Neurosci. 2014;17:813-21 pubmed 出版商
  33. Clynes D, Jelinska C, Xella B, Ayyub H, Taylor S, Mitson M, et al. ATRX dysfunction induces replication defects in primary mouse cells. PLoS ONE. 2014;9:e92915 pubmed 出版商
  34. Wojdyla L, Stone A, Sethakorn N, Uppada S, Devito J, Bissonnette M, et al. T-oligo as an anticancer agent in colorectal cancer. Biochem Biophys Res Commun. 2014;446:596-601 pubmed 出版商
  35. Schröder Heurich B, Wieland B, Lavin M, Schindler D, Dork T. Protective role of RAD50 on chromatin bridges during abnormal cytokinesis. FASEB J. 2014;28:1331-41 pubmed 出版商
  36. Sappino A, Buser R, Seguin Q, Fernet M, Lesne L, Gumy Pause F, et al. The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage. Oncogenesis. 2012;1:e7 pubmed 出版商
  37. Ogiwara H, Kohno T. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes. PLoS ONE. 2012;7:e52810 pubmed 出版商
  38. Zhang T, Penicud K, Bruhn C, Loizou J, Kanu N, Wang Z, et al. Competition between NBS1 and ATMIN controls ATM signaling pathway choice. Cell Rep. 2012;2:1498-504 pubmed 出版商
  39. Murad N, Cullen J, McKenzie M, Ryan M, Thorburn D, Gueven N, et al. Mitochondrial dysfunction in a novel form of autosomal recessive ataxia. Mitochondrion. 2013;13:235-45 pubmed 出版商
  40. Conradt L, Henrich A, Wirth M, Reichert M, Lesina M, Algül H, et al. Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death. Int J Cancer. 2013;132:2248-57 pubmed 出版商
  41. Anderson V, Walton M, Eve P, Boxall K, Antoni L, Caldwell J, et al. CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors. Cancer Res. 2011;71:463-72 pubmed 出版商
  42. Boichuk S, Hu L, Hein J, Gjoerup O. Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen. J Virol. 2010;84:8007-20 pubmed 出版商